1,428
Views
0
CrossRef citations to date
0
Altmetric
Review

Hemochromatosis: pathophysiology, evaluation, and management of hepatic iron overload with a focus on MRI

ORCID Icon, &
Pages 767-778 | Received 21 Mar 2018, Accepted 28 Jun 2018, Published online: 19 Jul 2018

References

  • Bacon BR, Adams PC, Kowdley KV, et al. Diagnosis and management of hemochromatosis: 2011 practice guideline by the American Association for the Study of Liver Diseases.. Hepatology.. 2011 Jul;54((1)):328–343. PubMed PMID: 21452290; PubMed Central PMCID: PMCPMC3149125.
  • Fleming RE, Ponka P. Iron overload in human disease. N Engl J Med. 2012 Jan 26;366(4):348–359. PubMed PMID: 22276824; eng.
  • Adams PC, Reboussin DM, Barton JC, et al. Hemochromatosis and iron-overload screening in a racially diverse population. N Engl J Med. 2005 Apr 28;352(17):1769–1778. PubMed PMID: 15858186; eng.
  • Phatak PD, Bonkovsky HL, Kowdley KV. Hereditary hemochromatosis: time for targeted screening. Ann Intern Med. 2008 Aug 19;149(4):270–272. PubMed PMID: 18711158; eng.
  • Pietrangelo A, Deugnier Y, Dooley J, et al.EASL clinical practice guidelines for HFE hemochromatosis. J Hepatol. 2010Jul;53(1):3–22. PubMed PMID: 20471131; eng
  • Feder JN, Gnirke A, Thomas W, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet. 1996 Aug;13(4):399–408. PubMed PMID: 8696333; eng.
  • Batts KP. Iron overload syndromes and the liver. Mod Pathol. 2007 Feb;20 Suppl 1:S31–9. PubMed PMID: 17486050.
  • Beutler E. The HFE Cys282Tyr mutation as a necessary but not sufficient cause of clinical hereditary hemochromatosis. Blood. 2003 May 01;101(9):3347–3350. . PubMed PMID: 12707220; eng.
  • Lazarescu A, Snively BM, Adams PC. Phenotype variation in C282Y homozygotes for the hemochromatosis gene. Clin Gastroenterol Hepatol. 2005 Oct;3(10):1043–1046. PubMed PMID: 16234052; eng.
  • Brittenham GM, Badman DG. National Institute of D, et al. Noninvasive measurement of iron: report of an NIDDK workshop. Blood. 2003 Jan 01;101(1):15–19. 10.1182/blood-2002-06-1723. PubMed PMID: 12393526.
  • Hernando D, Levin YS, Sirlin CB, et al. Quantification of liver iron with MRI: state of the art and remaining challenges. Journal of Magnetic Resonance Imaging: JMRI. 2014 Nov;40(5):1003–1021. PubMed PMID: 24585403; PubMed Central PMCID: PMCPMC4308740.
  • Andrews NC, Schmidt PJ. Iron homeostasis. Annu Rev Physiol. 2007;69:69–85. PubMed PMID: 17014365.
  • Brissot P, Ropert M, Le Lan C, et al. Non-transferrin bound iron: a key role in iron overload and iron toxicity. Biochim Biophys Acta. 2012 Mar;1820(3):403–410. PubMed PMID: 21855608; eng.
  • Kroot JJ, Tjalsma H, Fleming RE, et al. Hepcidin in human iron disorders: diagnostic implications. Clin Chem. 2011 Dec;57(12):1650–1669. PubMed PMID: 21989113.
  • Andrews NC. Closing the iron gate. N Engl J Med. 2012 Jan 26;366(4):376–377. . PubMed PMID: 22276828; eng.
  • Johnson MB, Enns CA. Diferric transferrin regulates transferrin receptor 2 protein stability. Blood. 2004 Dec 15;104(13):4287–4293. 10.1182/blood-2004-06-2477. PubMed PMID: 15319290.
  • Schmidt PJ, Toran PT, Giannetti AM, et al. The transferrin receptor modulates Hfe-dependent regulation of hepcidin expression. Cell Metab. 2008 Mar;7(3):205–214. PubMed PMID: 18316026; PubMed Central PMCID: PMCPMC2292811. eng.
  • Kautz L, Jung G, Valore EV, et al. Identification of erythroferrone as an erythroid regulator of iron metabolism. Nat Genet. 2014 Jul;46(7):678–684. PubMed PMID: 24880340; PubMed Central PMCID: PMCPMC4104984.
  • Cairo G, Recalcati S, Montosi G, et al. Inappropriately high iron regulatory protein activity in monocytes of patients with genetic hemochromatosis. Blood. 1997 Apr 01;89(7):2546–2553. PubMed PMID: 9116301; eng.
  • Wood MJ, Powell LW, Dixon JL, et al. Clinical cofactors and hepatic fibrosis in hereditary hemochromatosis: the role of diabetes mellitus. Hepatology. 2012 Sep;56(3):904–911. PubMed PMID: 22422567; eng.
  • Van Asbeck BS, Verbrugh HA, Van Oost BA, et al. Listeria monocytogenes meningitis and decreased phagocytosis associated with iron overload. Br Med J (Clin Res Ed). 1982 Feb 20;284(6315):542–544. PubMed PMID: 6800535; PubMed Central PMCID: PMCPMC1496163. eng.
  • Cherchi GB, Pacifico L, Cossellu S, et al. Prospective study of Yersinia enterocolitica infection in thalassemic patients. Pediatr Infect Dis J. 1995 Jul;14(7):579–584. PubMed PMID: 7567285; eng.
  • Gerhard GS, Levin KA, Price Goldstein J, et al. Vibrio vulnificus septicemia in a patient with the hemochromatosis HFE C282Y mutation. Arch Pathol Lab Med. 2001 Aug;125(8):1107–1109. PubMed PMID: 11473471; eng.
  • Niederau C, Strohmeyer G, Stremmel W. Epidemiology, clinical spectrum and prognosis of hemochromatosis. Adv Exp Med Biol. 1994;356: 293–302. PubMed PMID: 7887234; eng.
  • Zoller H, Henninger B. Pathogenesis, Diagnosis and Treatment of Hemochromatosis. Dig Dis. 2016;34(4):364–373. PubMed PMID: 27170390.
  • Fracanzani AL, Fargion S, Romano R, et al. Portal hypertension and iron depletion in patients with genetic hemochromatosis. Hepatology. 1995 Oct;22(4 Pt 1):1127–1131. PubMed PMID: 7557861; eng.
  • Morrison ED, Brandhagen DJ, Phatak PD, et al. Serum ferritin level predicts advanced hepatic fibrosis among U.S. patients with phenotypic hemochromatosis. Ann Intern Med. 2003 Apr 15;138(8):627–633. PubMed PMID: 12693884; eng.
  • Beaton M, Guyader D, Deugnier Y, et al. Noninvasive prediction of cirrhosis in C282Y-linked hemochromatosis. Hepatology. 2002 Sep;36(3):673–678. PubMed PMID: 12198660; eng.
  • Powell LW, Dixon JL, Ramm GA, et al. Screening for hemochromatosis in asymptomatic subjects with or without a family history. Arch Intern Med. 2006 Feb 13;166(3):294–301. PubMed PMID: 16476869; eng.
  • Olthof AW, Sijens PE, Kreeftenberg HG, et al. Correlation between serum ferritin levels and liver iron concentration determined by MR imaging: impact of hematologic disease and inflammation. Magn Reson Imaging. 2007 Feb;25(2):228–231. PubMed PMID: 17275618.
  • Gandon Y, Olivié D, Guyader D, et al. Non-invasive assessment of hepatic iron stores by MRI. The Lancet. 2004;363(9406):357–362. .
  • Nielsen P, Gunther U, Durken M, et al. Serum ferritin iron in iron overload and liver damage: correlation to body iron stores and diagnostic relevance. J Lab Clin Med. 2000 May;135(5):413–418. PubMed PMID: 10811057.
  • Henninger B, Kremser C, Rauch S, et al. Evaluation of MR imaging with T1 and T2* mapping for the determination of hepatic iron overload. Eur Radiol. 2012 Nov;22(11):2478–2486. PubMed PMID: 22645044.
  • Idilman IS, Akata D, Ozmen MN, et al. Different forms of iron accumulation in the liver on MRI. Diagn Interv Radiol. 2016 Jan-Feb;22(1):22–28. PubMed PMID: 26712679; PubMed Central PMCID: PMCPMC4712893.
  • Bravo AA, Sheth SG, Chopra S. Liver biopsy. N Engl J Med. 2001 Feb 15;344(7):495–500. . PubMed PMID: 11172192; eng.
  • Barry M, Sherlock S. Measurement of liver-iron concentration in needle-biopsy specimens. Lancet. 1971 Jan 16;1(7690):100–103. PubMed PMID: 4099600.
  • Villeneuve JP, Bilodeau M, Lepage R, et al. Variability in hepatic iron concentration measurement from needle-biopsy specimens. J Hepatol. 1996 Aug;25(2):172–177. PubMed PMID: 8878778.
  • Mortele KJ, Ros PR. Imaging of diffuse liver disease. Semin Liver Dis. 2001 May;21(2):195–212. . PubMed PMID: 11436572.
  • Boll DT, Merkle EM. Diffuse liver disease: strategies for hepatic CT and MR imaging. Radiographics. 2009 Oct;29(6):1591–1614. . PubMed PMID: 19959510.
  • Goldman IS, Winkler ML, Raper SE, et al. Increased hepatic density and phospholipidosis due to amiodarone. AJR Am J Roentgenol. 1985 Mar;144(3):541–546. PubMed PMID: 3871563.
  • De Maria M, De Simone G, Laconi A, et al. Gold storage in the liver: appearance on CT scans. Radiology. 1986 May;159(2):355–356. PubMed PMID: 3961168.
  • Akpinar E, Akhan O. Liver imaging findings of Wilson’s disease. Eur J Radiol. 2007 Jan;61(1):25–32. . PubMed PMID: 17161572.
  • Chandarana H, Lim RP, Jensen JH, et al. Hepatic iron deposition in patients with liver disease: preliminary experience with breath-hold multiecho T2*-weighted sequence. AJR Am J Roentgenol. 2009 Nov;193(5):1261–1267. PubMed PMID: 19843739.
  • Ghugre NR, Wood JC. Relaxivity-iron calibration in hepatic iron overload: probing underlying biophysical mechanisms using a monte carlo model. Magn Reson Med. 2011 Mar;65(3):837–847. . PubMed PMID: 21337413; PubMed Central PMCID: PMCPMC3065944.
  • Gandon Y, Guyader D, Heautot JF, et al. Hemochromatosis: diagnosis and quantification of liver iron with gradient-echo MR imaging. Radiology. 1994 Nov;193(2):533–538. PubMed PMID: 7972774.
  • al Ge. MRQuantif to quantify liver iron and fat by MRI University of Rennes, France[updated January 17, 2018;2018 Dec 6]. Available from: https://imagemed.univ-rennes1.fr/en/mrquantif/overview.php
  • Christoforidis A, Perifanis V, Spanos G, et al. MRI assessment of liver iron content in thalassamic patients with three different protocols: comparisons and correlations. Eur J Haematol. 2009 May;82(5):388–392. PubMed PMID: 19141120.
  • Alustiza Echeverria JM, Castiella A, Emparanza JI. Quantification of iron concentration in the liver by MRI. Insights Imaging. 2012 Apr;3(2):173–180. . PubMed PMID: 22696043; PubMed Central PMCID: PMCPMC3314738.
  • St Pierre TG, Clark PR, Chua-Anusorn W, et al. Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance. Blood. 2005 Jan 15;105(2):855–861. 10.1182/blood-2004-01-0177. PubMed PMID: 15256427.
  • Ferriscan - MRI MEASUREMENT OF LIVER IRON CONCENTRATION 2018 2018 10 6 Available from: www.ferriscan.com
  • St Pierre TG, Clark PR, Chua-Anusorn W. Single spin-echo proton transverse relaxometry of iron-loaded liver. NMR Biomed. 2004 Nov;17(7):446–458. . PubMed PMID: 15523601.
  • Krafft AJ, Loeffler RB, Song R, et al. Quantitative ultrashort echo time imaging for assessment of massive iron overload at 1.5 and 3 Tesla. Magn Reson Med. 2017 Jan 16 PubMed PMID: 28090666. DOI:10.1002/mrm.26592.
  • Sirlin CB, Reeder SB. Magnetic resonance imaging quantification of liver iron. Magn Reson Imaging Clin N Am. 2010 Aug;18(3):359–81, ix. PubMed PMID: 21094445; PubMed Central PMCID: PMCPMC3430384.
  • Wood JC, Enriquez C, Ghugre N, et al. MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients. Blood. 2005 Aug 15;106(4):1460–1465. 10.1182/blood-2004-10-3982. PubMed PMID: 15860670; PubMed Central PMCID: PMCPMC1895207.
  • Hankins JS, McCarville MB, Loeffler RB, et al. R2* magnetic resonance imaging of the liver in patients with iron overload. Blood. 2009 May 14;113(20):4853–4855. PubMed PMID: 19264677; PubMed Central PMCID: PMCPMC2686136.
  • Henninger B, Zoller H, Rauch S, et al. R2* relaxometry for the quantification of hepatic iron overload: biopsy-based calibration and comparison with the literature. Rofo. 2015 Jun;187(6):472–479. PubMed PMID: 25877992.
  • Storey P, Thompson AA, Carqueville CL, et al. R2* imaging of transfusional iron burden at 3T and comparison with 1.5T. Journal of Magnetic Resonance Imaging: JMRI. 2007 Mar;25(3):540–547. PubMed PMID: 17326089; PubMed Central PMCID: PMCPMC2884049.
  • Ghugre NR, Doyle EK, Storey P, et al. Relaxivity-iron calibration in hepatic iron overload: predictions of a monte carlo model. Magn Reson Med. 2015 Sep;74(3):879–883. PubMed PMID: 25242237; PubMed Central PMCID: PMCPMC4951155.
  • Westwood M, Anderson LJ, Firmin DN, et al. A single breath-hold multiecho T2* cardiovascular magnetic resonance technique for diagnosis of myocardial iron overload. Journal of Magnetic Resonance Imaging: JMRI. 2003 Jul;18(1):33–39. PubMed PMID: 12815637.
  • Westwood MA, Anderson LJ, Firmin DN, et al. Interscanner reproducibility of cardiovascular magnetic resonance T2* measurements of tissue iron in thalassemia. Journal of Magnetic Resonance Imaging: JMRI. 2003 Nov;18(5):616–620. . PubMed PMID: 14579406.
  • Chappell KE, Patel N, Gatehouse PD, et al. Magnetic resonance imaging of the liver with ultrashort TE (UTE) pulse sequences. Journal of Magnetic Resonance Imaging: JMRI. 2003 Dec;18(6):709–713. PubMed PMID: 14635156; eng.
  • Angelucci E, Muretto P, Nicolucci A, et al. Effects of iron overload and hepatitis C virus positivity in determining progression of liver fibrosis in thalassemia following bone marrow transplantation. Blood. 2002 Jul 01;100(1):17–21. PubMed PMID: 12070002.
  • Carneiro AA, Fernandes JP, De Araujo DB, et al. Liver iron concentration evaluated by two magnetic methods: magnetic resonance imaging and magnetic susceptometry. Magn Reson Med. 2005 Jul;54(1):122–128. PubMed PMID: 15968652.
  • Dyvorne HA, Jajamovich GH, Bane O, et al. Prospective comparison of magnetic resonance imaging to transient elastography and serum markers for liver fibrosis detection. Liver Int. 2016 May;36(5):659–666. PubMed PMID: 26744140; PubMed Central PMCID: PMCPMC4842106.
  • Huwart L, Sempoux C, Vicaut E, et al. Magnetic resonance elastography for the noninvasive staging of liver fibrosis. Gastroenterology. 2008 Jul;135(1):32–40. PubMed PMID: 18471441; eng.
  • Wang Y, Ganger DR, Levitsky J, et al. Assessment of chronic hepatitis and fibrosis: comparison of MR elastography and diffusion-weighted imaging. AJR Am J Roentgenol. 2011 Mar;196(3):553–561. PubMed PMID: 21343496; PubMed Central PMCID: PMCPMC3093963.
  • Yin M, Talwalkar JA, Glaser KJ, et al. Assessment of hepatic fibrosis with magnetic resonance elastography. Clin Gastroenterol Hepatol. 2007 Oct;5(10):1207–1213 e2. PubMed PMID: 17916548; PubMed Central PMCID: PMCPMC2276978.
  • Wu WP, Chou CT, Chen RC, et al. Non-Invasive evaluation of hepatic fibrosis: the diagnostic performance of magnetic resonance elastography in patients with viral hepatitis b or c. PLoS One. 2015;10(10):e0140068. PubMed PMID: 26469342; PubMed Central PMCID: PMCPMC4607490.
  • Wagner M, Corcuera-Solano I, Lo G, et al. Technical failure of mr elastography examinations of the liver: experience from a large single-center study. Radiology. 2017 Jan 03:160863. PubMed PMID: 28045604. DOI: 10.1148/radiol.2016160863
  • Wagner M, Besa C, Bou Ayache J, et al. Magnetic resonance elastography of the liver: qualitative and quantitative comparison of gradient echo and spin echo echoplanar imaging sequences. Invest Radiol. 2016 Sep;51(9):575–581. PubMed PMID: 26982699.
  • Horng DE, Hernando D, Reeder SB. Quantification of liver fat in the presence of iron overload. Journal of Magnetic Resonance Imaging: JMRI. 2017 Feb;45(2):428–439. . PubMed PMID: 27405703; PubMed Central PMCID: PMCPMC5420327.
  • Lee YJ, Lee JM, Lee JS, et al. Hepatocellular carcinoma: diagnostic performance of multidetector CT and MR imaging-a systematic review and meta-analysis. Radiology. 2015 Apr;275(1):97–109. PubMed PMID: 25559230.
  • Friedrich-Rust M, Ong MF, Martens S, et al. Performance of transient elastography for the staging of liver fibrosis: a meta-analysis. Gastroenterology. 2008 Apr;134(4):960–974. PubMed PMID: 18395077; eng.
  • Manning DS, Afdhal NH. Diagnosis and quantitation of fibrosis. Gastroenterology. 2008 May;134(6):1670–1681. . PubMed PMID: 18471546; eng.
  • Ong SY, Dolling L, Dixon JL, et al. Should HFE p.C282Y homozygotes with moderately elevated serum ferritin be treated? A randomised controlled trial comparing iron reduction with sham treatment (Mi-iron). BMJ Open. 2015 Aug 12;5(8):e008938. PubMed PMID: 26270952; PubMed Central PMCID: PMCPMC4538285. eng.
  • Andersen ES, Christensen PB, Weis N. Transient elastography for liver fibrosis diagnosis. Eur J Intern Med. 2009 Jul;20(4):339–342. . PubMed PMID: 19524169; eng.
  • Talwalkar JA, Kurtz DM, Schoenleber SJ, et al. Ultrasound-based transient elastography for the detection of hepatic fibrosis: systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2007 Oct;5(10):1214–1220. PubMed PMID: 17916549; eng.
  • Adhoute X, Foucher J, Laharie D, et al. Diagnosis of liver fibrosis using FibroScan and other noninvasive methods in patients with hemochromatosis: a prospective study. Gastroenterol Clin Biol. 2008 Feb;32(2):180–187. PubMed PMID: 18496894; eng.
  • Legros L, Bardou-Jacquet E, Latournerie M, et al. Non-invasive assessment of liver fibrosis in C282Y homozygous HFE hemochromatosis. Liver Int. 2015 Jun;35(6):1731–1738. PubMed PMID: 25495562; eng.
  • Castera L, Foucher J, Bernard PH, et al. Pitfalls of liver stiffness measurement: a 5-year prospective study of 13,369 examinations. Hepatology. 2010 Mar;51(3):828–835. PubMed PMID: 20063276; eng.
  • Paparo F, Cevasco L, Zefiro D, et al. Diagnostic value of real-time elastography in the assessment of hepatic fibrosis in patients with liver iron overload. Eur J Radiol. 2013 Dec;82(12):e755–61. PubMed PMID: 24050879; eng.
  • Adams PC, Speechley M, Kertesz AE. Long-term survival analysis in hereditary hemochromatosis. Gastroenterology. 1991 Aug;101(2):368–372. PubMed PMID: 2065912; eng.
  • Niederau C, Fischer R, Purschel A, et al. Long-term survival in patients with hereditary hemochromatosis. Gastroenterology. 1996 Apr;110(4):1107–1119. PubMed PMID: 8613000; eng.
  • Falize L, Guillygomarc’h A, Perrin M, et al. Reversibility of hepatic fibrosis in treated genetic hemochromatosis: a study of 36 cases. Hepatology. 2006 Aug;44(2):472–477. PubMed PMID: 16871557; eng.
  • Hutchinson C, Geissler CA, Powell JJ, et al. Proton pump inhibitors suppress absorption of dietary non-haem iron in hereditary haemochromatosis. Gut. 2007 Sep;56(9):1291–1295. PubMed PMID: 17344278; PubMed Central PMCID: PMCPMC1954964. eng.
  • Franchini M, Targher G, Capra F, et al. The effect of iron depletion on chronic hepatitis C virus infection. Hepatol Int. 2008 Sep;2(3):335–340. PubMed PMID: 19669262; PubMed Central PMCID: PMCPMC2716881. eng.
  • Facchini FS, Hua NW, Stoohs RA. Effect of iron depletion in carbohydrate-intolerant patients with clinical evidence of nonalcoholic fatty liver disease. Gastroenterology. 2002 Apr;122(4):931–939. PubMed PMID: 11910345; eng.
  • Valenti L, Fracanzani AL, Dongiovanni P, et al. Iron depletion by phlebotomy improves insulin resistance in patients with nonalcoholic fatty liver disease and hyperferritinemia: evidence from a case-control study. Am J Gastroenterol. 2007 Jun;102(6):1251–1258. PubMed PMID: 17391316; eng.
  • Laine F, Ruivard M, Loustaud-Ratti V, et al. Metabolic and hepatic effects of bloodletting in dysmetabolic iron overload syndrome: A randomized controlled study in 274 patients. Hepatology. 2017 Feb;65(2):465–474. PubMed PMID: 27685251; eng.
  • Rombout-Sestrienkova E, Nieman FH, Essers BA, et al. Erythrocytapheresis versus phlebotomy in the initial treatment of HFE hemochromatosis patients: results from a randomized trial. Transfusion. 2012 Mar;52(3):470–477. PubMed PMID: 21848963; eng.
  • Bruckl D, Kamhieh-Milz S, Kamhieh-Milz J, et al. Efficacy and safety of erythrocytapheresis and low-dose erythropoietin for treatment of hemochromatosis. J Clin Apher. 2016 Jun 08 PubMed PMID: 27271482; eng. 10.1002/jca.21477.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.